{"id":473,"date":"2026-08-28T06:56:05","date_gmt":"2026-08-28T06:56:05","guid":{"rendered":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/"},"modified":"2026-08-28T07:31:46","modified_gmt":"2026-08-28T07:31:46","slug":"ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary","status":"publish","type":"post","link":"https:\/\/nhdbio.com\/pt-br\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","title":{"rendered":"Limites de evid\u00eancia LL-37: pept\u00eddeo end\u00f3geno, entrega projetada e material de cat\u00e1logo"},"content":{"rendered":"<p class=\"pim-standfirst wp-block-paragraph\">\u201cLL-37\u201d pode referir-se a um pept\u00eddeo de defesa humana end\u00f3geno, um reagente de ensaio sint\u00e9tico ou um sistema de distribui\u00e7\u00e3o biol\u00f3gica projetado. Os resultados de uma dessas interven\u00e7\u00f5es n\u00e3o podem ser transferidos automaticamente para outra.<\/p><div class=\"wp-block-group pim-key-takeaways\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><h2 class=\"wp-block-heading\">O que o registro mostra<\/h2><ul class=\"wp-block-list\"><li>A express\u00e3o end\u00f3gena n\u00e3o \u00e9 evid\u00eancia de administra\u00e7\u00e3o ex\u00f3gena.<\/li><li>Um organismo modificado que expressa LL-37 n\u00e3o \u00e9 equivalente a LL-37 sint\u00e9tico isolado.<\/li><li>FDA relata informa\u00e7\u00f5es insuficientes sobre seguran\u00e7a humana e sinaliza preocupa\u00e7\u00f5es sobre imunogenicidade, reprodu\u00e7\u00e3o e tumores espec\u00edficos de tecidos.<\/li><\/ul><\/div><\/div><figure class=\"wp-block-image size-full pim-article-figure\"><img loading=\"lazy\" decoding=\"async\" width=\"1536\" height=\"1024\" src=\"http:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828.png\" alt=\"Cientista revisando ensaios bacterianos e dados de pesquisa de membranas pept\u00eddicas\" class=\"wp-image-461\" srcset=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828.png 1536w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828-300x200.png 300w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828-1024x683.png 1024w, https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/ll37-antimicrobial-research-20260828-768x512.png 768w\" sizes=\"auto, (max-width: 1536px) 100vw, 1536px\" \/><figcaption class=\"wp-element-caption\">Ilustra\u00e7\u00e3o editorial original utilizada para identificar o tema da pesquisa. N\u00e3o representa lote de cat\u00e1logo, medicamento aprovado, resultado de ensaio ou uso cl\u00ednico.<\/figcaption><\/figure><h2 class=\"wp-block-heading\">O limite de identidade e evid\u00eancia<\/h2><p class=\"wp-block-paragraph\">Um artigo sobre um microrganismo que expressa LL-37 testa a interven\u00e7\u00e3o de engenharia completa, incluindo seu sistema de entrega. N\u00e3o deve ser citado como se os participantes tivessem recebido um frasco de LL-37 isolado.<\/p><div class=\"wp-block-group pim-evidence-table\"><div class=\"wp-block-group__inner-container is-layout-flow wp-block-group-is-layout-flow\"><div class=\"pim-evidence-row\"><strong>Contexto end\u00f3geno<\/strong><span>Catelicidina humana na imunidade inata<\/span><\/div><div class=\"pim-evidence-row\"><strong>Contexto do ensaio<\/strong><span>Pept\u00eddeo sint\u00e9tico sob condi\u00e7\u00f5es in vitro especificadas<\/span><\/div><div class=\"pim-evidence-row\"><strong>Contexto de seguran\u00e7a<\/strong><span>FDA identifica grandes lacunas de informa\u00e7\u00e3o e preocupa\u00e7\u00f5es n\u00e3o cl\u00ednicas<\/span><\/div><\/div><\/div><h2 class=\"wp-block-heading\">O que pertence ao registro material<\/h2><p class=\"wp-block-paragraph\">Para caracteriza\u00e7\u00e3o de materiais, confirma\u00e7\u00e3o de sequ\u00eancia, pureza, massa, agrega\u00e7\u00e3o e controles de endotoxinas ou carga biol\u00f3gica respondem a diferentes quest\u00f5es. Nenhum fornece uma conclus\u00e3o sobre a efic\u00e1cia humana.<\/p><h2 class=\"wp-block-heading\">Regra editorial<\/h2><p class=\"wp-block-paragraph\">Use o nome exato da interven\u00e7\u00e3o, modelo, popula\u00e7\u00e3o e desfecho do registro citado. N\u00e3o converta uma associa\u00e7\u00e3o, mecanismo, resultado animal, registro de medicamento acabado aprovado ou teste anal\u00edtico em uma afirma\u00e7\u00e3o sobre um lote de cat\u00e1logo n\u00e3o relacionado.<\/p>","protected":false},"excerpt":{"rendered":"<p>\u201cLL-37\u201d pode referir-se a um pept\u00eddeo de defesa humana end\u00f3geno, um reagente de ensaio sint\u00e9tico ou um sistema de distribui\u00e7\u00e3o biol\u00f3gica projetado. Os resultados de uma dessas interven\u00e7\u00f5es n\u00e3o podem ser transferidos automaticamente para outra.<\/p>","protected":false},"author":1,"featured_media":638,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pim_family_ids":"348","pim_article_type":"Evidence and material-quality guide","pim_evidence_level":"In-vitro evidence and current FDA safety assessment","pim_reviewer":"NHD evidence editorial workflow","pim_reviewed_date":"2026-08-28","pim_editorial_note":"Source-checked on 2026-08-28. Null findings and study limitations are retained. This is not independent peer review, medical advice, a customer case, or validation of a catalog lot.","pim_review_status":"reviewed","pim_review_reason":"At least two linked primary or authoritative records and an explicit evidence boundary are present.","pim_creation_method":"The editorial workflow starts with linked peer-reviewed papers, trial registries or regulatory records; extracts the population or model, endpoints, numerical results and limitations; and separates the studied intervention from catalog material. AI-assisted drafting was used to structure the first version. Claims, figures, evidence labels and limitations were checked against the linked records in the site editorial workflow. This is not independent peer review.","pim_sources":"[{\"title\":\"LL-37 ocular expression and antimicrobial activity\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16020269\/\",\"note\":\"Human tissue expression and in-vitro assays; PMID 16020269.\"},{\"title\":\"LL-37 analog activity, cytotoxicity and serum inhibition\",\"url\":\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15980359\/\",\"note\":\"In-vitro context; PMID 15980359.\"},{\"title\":\"FDA list of bulk substances with significant safety concerns\",\"url\":\"https:\/\/www.fda.gov\/drugs\/human-drug-compounding\/certain-bulk-drug-substances-use-compounding-may-present-significant-safety-risks\",\"note\":\"Current FDA LL-37 safety summary.\"}]","footnotes":""},"categories":[20],"tags":[],"class_list":["post-473","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-evidence-quality-guides"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.1) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>LL-37 Evidence Boundaries: Endogenous vs Engineered<\/title>\n<meta name=\"description\" content=\"\u201cLL-37\u201d can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one of those\u2026\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nhdbio.com\/pt-br\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material\" \/>\n<meta property=\"og:description\" content=\"\u201cLL-37\u201d can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one of those\u2026\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nhdbio.com\/pt-br\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/\" \/>\n<meta property=\"og:site_name\" content=\"NHD\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-28T06:56:05+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-28T07:31:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1536\" \/>\n\t<meta property=\"og:image:height\" content=\"960\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"NHD Technical Team\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Peptide Raw Materials and Custom Peptide Synthesis\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"NHD Technical Team\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\"},\"author\":{\"name\":\"NHD Technical Team\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\"},\"headline\":\"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\"},\"wordCount\":227,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\",\"articleSection\":[\"Evidence &amp; Quality Guides\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\",\"name\":\"LL-37 Evidence Boundaries: Endogenous vs Engineered\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\",\"datePublished\":\"2026-08-28T06:56:05+00:00\",\"dateModified\":\"2026-08-28T07:31:46+00:00\",\"description\":\"\u201cLL-37\u201d can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one of those\u2026\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/generated-news\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp\",\"width\":1536,\"height\":960,\"caption\":\"Article-specific editorial image.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nhdbio.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#website\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"name\":\"NHD\",\"description\":\"Peptide Raw Materials and Custom Peptide Synthesis\",\"publisher\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nhdbio.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#organization\",\"name\":\"NHD\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"contentUrl\":\"https:\\\/\\\/nhdbio.com\\\/wp-content\\\/uploads\\\/2026\\\/09\\\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png\",\"width\":2172,\"height\":724,\"caption\":\"NHD\"},\"image\":{\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nhdbio.com\\\/#\\\/schema\\\/person\\\/0ffb0dec7fda0f720073fc468fac6fc1\",\"name\":\"NHD Technical Team\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g\",\"caption\":\"NHD Technical Team\"},\"description\":\"NHD Technical Team maintains research-use catalog documentation and evidence summaries. Reviewed articles link to peer-reviewed papers, trial registries and regulatory records, retain null findings and study limitations, and distinguish published interventions from catalog materials. AI-assisted drafting may be used for structure; source links and evidence boundaries remain visible. This work is not independent peer review or medical advice.\",\"sameAs\":[\"https:\\\/\\\/nhdbio.com\"],\"url\":\"https:\\\/\\\/nhdbio.com\\\/pt-br\\\/author\\\/qianmiao-technical-team\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Limites de evid\u00eancia LL-37: end\u00f3geno vs projetado","description":"\u201cLL-37\u201d pode referir-se a um pept\u00eddeo de defesa humana end\u00f3geno, um reagente de ensaio sint\u00e9tico ou um sistema de distribui\u00e7\u00e3o biol\u00f3gica projetado. Resultados de um desses ...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nhdbio.com\/pt-br\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","og_locale":"pt_BR","og_type":"article","og_title":"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material","og_description":"\u201cLL-37\u201d can refer to an endogenous human defense peptide, a synthetic assay reagent or an engineered biological delivery system. Results from one of those\u2026","og_url":"https:\/\/nhdbio.com\/pt-br\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","og_site_name":"NHD","article_published_time":"2026-08-28T06:56:05+00:00","article_modified_time":"2026-08-28T07:31:46+00:00","og_image":[{"width":1536,"height":960,"url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","type":"image\/webp"}],"author":"NHD Technical Team","twitter_card":"summary_large_image","twitter_description":"Peptide Raw Materials and Custom Peptide Synthesis","twitter_misc":{"Escrito por":"NHD Technical Team","Est. tempo de leitura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#article","isPartOf":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/"},"author":{"name":"NHD Technical Team","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1"},"headline":"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/"},"wordCount":227,"commentCount":0,"publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"image":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","articleSection":["Evidence &amp; Quality Guides"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","url":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/","name":"Limites de evid\u00eancia LL-37: end\u00f3geno vs projetado","isPartOf":{"@id":"https:\/\/nhdbio.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#primaryimage"},"image":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#primaryimage"},"thumbnailUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","datePublished":"2026-08-28T06:56:05+00:00","dateModified":"2026-08-28T07:31:46+00:00","description":"\u201cLL-37\u201d pode referir-se a um pept\u00eddeo de defesa humana end\u00f3geno, um reagente de ensaio sint\u00e9tico ou um sistema de distribui\u00e7\u00e3o biol\u00f3gica projetado. Resultados de um desses ...","breadcrumb":{"@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#primaryimage","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/08\/generated-news\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary-featured-v2.webp","width":1536,"height":960,"caption":"Article-specific editorial image."},{"@type":"BreadcrumbList","@id":"https:\/\/nhdbio.com\/ll-37-endogenous-peptide-vs-engineered-intervention-evidence-boundary\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nhdbio.com\/"},{"@type":"ListItem","position":2,"name":"LL-37 Evidence Boundaries: Endogenous Peptide, Engineered Delivery and Catalog Material"}]},{"@type":"WebSite","@id":"https:\/\/nhdbio.com\/#website","url":"https:\/\/nhdbio.com\/","name":"NHD","description":"Mat\u00e9rias-primas pept\u00eddicas e s\u00edntese personalizada","publisher":{"@id":"https:\/\/nhdbio.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nhdbio.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/nhdbio.com\/#organization","name":"NHD","url":"https:\/\/nhdbio.com\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/","url":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","contentUrl":"https:\/\/nhdbio.com\/wp-content\/uploads\/2026\/09\/codex-clipboard-354c928e-4b5b-482d-9261-02023d4c9680.png","width":2172,"height":724,"caption":"NHD"},"image":{"@id":"https:\/\/nhdbio.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/nhdbio.com\/#\/schema\/person\/0ffb0dec7fda0f720073fc468fac6fc1","name":"Equipe T\u00e9cnica NHD","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/8445618b3e2834fa0c7ae1a03a371ed002e9bf8d2cc1cd989dc4a71bb2b66110?s=96&d=mm&r=g","caption":"NHD Technical Team"},"description":"A equipe t\u00e9cnica NHD mant\u00e9m documenta\u00e7\u00e3o de cat\u00e1logo de uso em pesquisa e resumos de evid\u00eancias. Os artigos revisados \u200b\u200bvinculam-se a artigos revisados \u200b\u200bpor pares, registros de ensaios e registros regulat\u00f3rios, ret\u00eam resultados nulos e limita\u00e7\u00f5es de estudos e distinguem interven\u00e7\u00f5es publicadas de materiais de cat\u00e1logo. O desenho assistido por AI pode ser usado para estrutura; os links de origem e os limites das evid\u00eancias permanecem vis\u00edveis. Este trabalho n\u00e3o \u00e9 uma revis\u00e3o independente por pares ou aconselhamento m\u00e9dico.","sameAs":["https:\/\/nhdbio.com"],"url":"https:\/\/nhdbio.com\/pt-br\/author\/qianmiao-technical-team\/"}]}},"_links":{"self":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/473","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/comments?post=473"}],"version-history":[{"count":1,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/473\/revisions"}],"predecessor-version":[{"id":503,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/posts\/473\/revisions\/503"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/media\/638"}],"wp:attachment":[{"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/media?parent=473"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/categories?post=473"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhdbio.com\/pt-br\/wp-json\/wp\/v2\/tags?post=473"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}